First Interstate Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

First Interstate Bank’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,500	Closed	-$410K	–	746
2016 Q3	$410K	Hold	2,500	–	–	0.08%	133
2016 Q2	$358K	Hold	2,500	–	–	0.07%	144
2016 Q1	$342K	Hold	2,500	–	–	0.07%	146
2015 Q4	$347K	Hold	2,500	–	–	0.07%	147
2015 Q3	$336K	Buy	+2,500	New	+$360K	0.07%	147

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

First Interstate Bank's BIO Position: Q4 2016 in Review

First Interstate Bank sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2016, closing a stake of 2,500 shares — an estimated $410K sold.

First Interstate Bank first reported a position in BIO in Q3 2015 and held it in 5 quarters. The position peaked at $410K in Q3 2016. 261 funds tracked by Wall St. Rank hold BIO as of Q4 2016.

First Interstate Bank reported no remaining Bio-Rad Laboratories Class A position as of Q4 2016 after selling out during the quarter.
First Interstate Bank sold 2,500 Bio-Rad Laboratories Class A shares in Q4 2016, an estimated $410K.
First Interstate Bank first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and held it in 5 quarters.
First Interstate Bank's Bio-Rad Laboratories Class A position peaked at $410K in Q3 2016.
261 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2016.

Based on First Interstate Bank's 13F filing for Q4 2016, filed 31 Jan 2017.